rhamnose
Small moleculeexperimental
Rhamnose is a naturally occurring deoxy sugar. It can be classified as either a methyl-pentose or a 6-deoxy-hexose. Rhamnose predominantly occurs in nature in its L-form as L-rhamnose (6-deoxy-L-mannose). This is unusual, since most of the naturally occurring sugars are in D-form. Exceptions are the methyl pentoses L-fucose and L-rhamnose and the pentose L-arabinose. However, examples of naturally occurring D-rhamnose are found in some species of bacteria, such as Pseudomonas aeruginosa and Helicobacter pylori. — Wikipedia
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2013 (NCT01756040)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- rhamnoseSupplementation
rhamnose supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaRhamnose ↗
Also known as
- l-rhamnose
- l-rhamnose
- rhamnose
- rhamnose
- rhamnose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05651230 | N/A | Jan 1, 2023 | University of Texas, Austin |
| NCT03962998 | Early Phase 1 (Phase 1) | Aug 31, 2019 | MediBeacon |
| NCT01756040 | Phase 1 | Feb 1, 2013 | Harvard University, National Center for Complementary and Integrative Health (NCCIH), University of Maryland |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| MediBeacon | For profit | 1 | 1 | 1 | 2019 |
| National Center for Complementary and Integrative Health (NCCIH) | Government | 1 | 0 | 1 | 2013 |
| University of Maryland | Academic/Hospital | 1 | 1 | 1 | 2013 |
| University of Texas, Austin | Academic/Hospital | 1 | 1 | 1 | 2023 |
5 organizations
Page 1 / 1